Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin

5 May 2023

Abstract excerpt

Ovarian cancer (OC) is a refractory cancer that shows recurrence due to the acquisition of resistance to anticancer drugs, including cisplatin. However, the molecular mechanism underlying the acquisition of cisplatin resistance by cancer cells remains largely unknown. In the present study, two sets of ovarian endometrioid carcinoma cell lines were used: The parental A2780 cell line, the OVK18 cell line, and their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37144519
DOI: 10.3892/or.2023.8561

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatinPMID 37144519Read ↗

Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potentialSemantic proximity Read ↗

Inhibition of TPI1 Sensitizes Cisplatin-Resistant Oral Cancer to FerroptosisSemantic proximity Read ↗

MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathwaysSemantic proximity Read ↗

Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer.Semantic proximity Read ↗

Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanismsSemantic proximity Read ↗

Nuclear receptor subfamily 1 group D member 2 induces chemoresistance in ovarian cancer by regulating ferroptosis and immune infiltrationSemantic proximity Read ↗

Molecular mechanisms of cisplatin resistance in ovarian cancerSemantic proximity Read ↗

Ovarian Cancer—Insights into Platinum Resistance and Overcoming ItSemantic proximity Read ↗

Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancerSemantic proximity Read ↗

A panel of three oxidative stress-related genes predicts overall survival in ovarian cancer patients received platinum-based chemotherapySemantic proximity Read ↗

Down-regulated FDX1 inhibited the proliferation and migration of renal cell carcinoma cellsSemantic proximity Read ↗

ABCF2 , an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.